BIIB
$150.03
Revenue | $2465.8Mn |
Net Profits | $388.5Mn |
Net Profit Margins | 15.76% |
Biogen Inc.’s revenue fell -2.55% since last year same period to $2465.8Mn in the Q3 2024. On a quarterly growth basis, Biogen Inc. has generated 4.79% jump in its revenue since last 3-months.
Biogen Inc.’s net profit jumped 670.48% since last year same period to $388.5Mn in the Q3 2024. On a quarterly growth basis, Biogen Inc. has generated -33.43% fall in its net profits since last 3-months.
Biogen Inc.’s net profit margin jumped 685.41% since last year same period to 15.76% in the Q3 2024. On a quarterly growth basis, Biogen Inc. has generated -36.48% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 3.79 |
EPS Estimate Current Year | 3.79 |
Biogen Inc.’s earning per share (EPS) estimates for the current quarter stand at 3.79 - a -5.96% fall from last quarter’s estimates.
Biogen Inc.’s earning per share (EPS) estimates for the current year stand at 3.79.
Earning Per Share (EPS) | 4.08 |
Biogen Inc.’s earning per share (EPS) fell -6.42% since last year same period to 4.08 in the Q3 2024. This indicates that the Biogen Inc. has generated -6.42% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-08-01 | 4.03 | 5.28 | 31.02% |
2024-04-24 | 3.45 | 3.67 | 6.38% |
2024-10-30 | 3.79 | 4.08 | 7.65% |